Arteriovenous Fistula Toxicity | Zendy

Richard Amerling | Zendy; Claudio Ronco | Zendy; Martin Kuhlman | Zendy; James F. Winchester | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Arteriovenous Fistula Toxicity

Author(s) -

Richard Amerling,

Claudio Ronco,

Martin Kuhlman,

James F. Winchester

Publication year - 2011

Publication title -

blood purification

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.686

H-Index - 57

eISSN - 1421-9735

pISSN - 0253-5068

DOI - 10.1159/000322695

Subject(s) - arteriovenous fistula , medicine , hemodialysis , toxicity , cardiac toxicity , fistula , vascular access , surgery , cardiology , intensive care medicine

The arteriovenous fistula (AVF) has been a mainstay of hemodialysis treatments and the preferred access route since its inception in the 1960s, due to its longevity and resistance to infection. However, the AVF is not benign. There is significant primary failure, as well as cardiac, vascular, and other, less well recognized, complications. Together, they represent toxicity, to which considerable morbidity and mortality can be attached. Official policy, based on guidelines where AVF toxicity is given short shrift, drives an increase in use of these devices, and may have undesired consequences.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research